StockNews.AI
TOMZ
StockNews.AI
68 days

SteraMist Named Disinfection and Decontamination Products Company of the Year 2025

1. TOMI received 'Company of the Year 2025' for disinfection products. 2. Recognition underscores confidence in SteraMist iHP technology's effectiveness. 3. Award evaluated by industry leaders and experts in the field. 4. TOMI aims to advance its iHP technology further for market leadership. 5. Products serve various sectors like healthcare, education, and emergency services.

6m saved
Insight
Article

FAQ

Why Bullish?

Awards enhance TOMZ's brand credibility and attractiveness, often correlating with increased stock prices, as seen with other recognized firms in the sector. Companies receiving industry accolades like this tend to experience upward momentum in market perception and investor interest.

How important is it?

The award is a significant validation of TOMZ’s products, which can drive sales and attract investments. Recognition from a reputable source can lead to increased demand from both existing and new clients, enhancing revenue potential.

Why Short Term?

Award announcements can lead to immediate investor enthusiasm and potential upticks in shares, typically reflected in market reactions within days or weeks. Long-term benefits depend on TOMZ's ability to sustain growth and continue innovation.

Related Companies

CRBPINFICMDX
FREDERICK, Md., June 12, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today is proud to announce it has been honored with the prestigious "Disinfection and Decontamination Products Company of the Year 2025" award by MedTech Outlook. This recognition highlights TOMI’s unwavering commitment to excellence and the strong confidence customers and industry peers have in its SteraMist iHP technology. The selection process for this esteemed award involved an evaluation conducted by an expert panel of highly respected C-level executives, influential industry thought leaders, and a distinguished editorial board. Their collective assessment led to SteraMist emerging as the clear leader in disinfection and decontamination products for 2025. "We are incredibly honored to receive this prestigious award,” stated Dr. Halden Shane, CEO of TOMI Environmental Solutions. “This recognition validates our ongoing commitment to providing the most effective and trusted disinfection and decontamination technology to our customers. We are especially grateful for the support and the industry experts who recognized our efforts." SteraMist remains dedicated to advancing its innovative iHP technology and maintaining its position at the forefront of the disinfection and decontamination industry, continuously striving to exceed the expectations of its global customer base. TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments. For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. INVESTOR RELATIONS CONTACT:John Nesbett/Rosalyn ChristianIMS Investor Relationstomi@imsinvestorrelations.com

Related News